This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Warnke, R. A. Articles by Mason, D. Y. Search for Related Content PubMed PubMed Citation Articles by Warnke, R. A. Articles by Mason, D. Y.

American Journal of Pathology, Vol 135, 1089-1095, Copyright © 1989 by American Society for Investigative Pathology

REGULAR ARTICLES

Diagnosis of myelomonocytic and macrophage neoplasms in routinely processed tissue biopsies with monoclonal antibody KP1

RA Warnke, KA Pulford, G Pallesen, E Ralfkiaer, DC Brown, KC Gatter and DY Mason
Nuffield Department of Pathology, John Radcliffe Hospital, Oxford, England.

A new monoclonal antibody, KP1, against the CD68 antigen, which labels macrophages and other members of the mononuclear phagocyte lineage in routinely processed tissue sections, has been used to stain a range of lymphoid, histiocytic, and myelomonocytic proliferations. All 20 neoplasms of myeloid, myelomonocytic, and presumed macrophage derivation reacted with antibody KP1. None of the 22 cases of T cell neoplasia had positive reactions. Although 14 of 41 B lineage lymphomas and leukaemias were stained by antibody KP1, staining was usually confined to small dots of reactivity, in contrast to the strong and extensive cytoplasmic staining seen in the neoplasms of myeloid and macrophage/monocyte origin. Furthermore, positive B cell neoplasms were almost all small cell proliferations, which are unlikely to be confused with myelomonocytic malignancies. It was concluded that antibody KP1 is a valuable addition to a panel of monoclonal antibodies for phenotyping lymphomas, particularly in routinely fixed tissues. It should assist the pathologist in the recognition of extramedullary presentation of leukaemia, aid in the diagnosis of suspected cases of true histiocytic neoplasia, and allow for quantitation of macrophages infiltrating lymphomas and other solid tumors.

This article has been cited by other articles:

				P H McGuinness, D Painter, S Davies, and G W McCaughan Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection Gut, February 1, 2000; 46(2): 260 - 269. [Abstract] [Full Text] [PDF]

				P. E. McKeever Insights About Brain Tumors Gained Through Immunohistochemistry and in Situ Hybridization of Nuclear and Phenotypic Markers J. Histochem. Cytochem., May 1, 1998; 46(5): 585 - 594. [Abstract] [Full Text]

				A. C. Li, F. R. B. Guidez, J. G. Collier, and C. K. Glass The Macrosialin Promoter Directs High Levels of Transcriptional Activity in Macrophages Dependent on Combinatorial Interactions between PU.1 and c-Jun J. Biol. Chem., February 27, 1998; 273(9): 5389 - 5399. [Abstract] [Full Text] [PDF]

				C. E. Murry, T. Bartosek, C. M. Giachelli, C. E. Alpers, and S. M. Schwartz Platelet-Derived Growth Factor–A mRNA Expression in Fetal, Normal Adult, and Atherosclerotic Human Aortas : Analysis by Competitive Polymerase Chain Reaction Circulation, March 15, 1996; 93(6): 1095 - 1106. [Abstract] [Full Text]